Table 2. Factors associated with treatment delay among patients with MDR-TB.
Variables | Treatment Delay n (%) |
CRR (95% CI) | ARR (95% CI) | |
---|---|---|---|---|
Short delay | Long delay | |||
Sex | ||||
Male | 120 (56.1) | 94 (43.9) | 1.00 | 1.00 |
Female | 40 (34.5) | 76 (65.5) | 1.49 (1.10–2.02) * | 1.40 (1.03–1.91) * |
Age | ||||
≤ 30 years | 66 (66.7) | 33 (33.3) | 1.00 | 1.00 |
31–50 years | 66 (40.7) | 96 (59.3) | 1.78 (1.19–2.64) * | 1.71 (1.15–2.57) * |
> 50 years | 28 (40.6) | 41 (59.4) | 1.78 (1.13–2.82) * | 1.77 (1.11–2.82) * |
Type of patient | ||||
New case | 9 (25.7) | 26 (74.3) | 1.00 | 1.00 |
Previously treated case | 151 (51.2) | 144 (48.8) | 0.66 (0.43–0.99) * | 0.93 (0.58–1.50) |
Contact with MDR-TB patient | ||||
Absent | 123 (58.0) | 89 (42.0) | 1.00 | 1.00 |
Present | 37 (31.4) | 81 (68.6) | 1.64 (1.21–2.21) * | 1.48 (1.06–2.08) * |
Diabetes mellitus | ||||
Absent | 152 (50.5) | 149 (49.5) | 1.00 | 1.00 |
Present | 8 (27.6) | 21 (72.4) | 1.46 (0.93–2.31) | 1.09 (0.68–1.76) |
HIV coinfection | ||||
Absent | 150 (50.3) | 148 (49.7) | 1.00 | 1.00 |
Present | 10 (31.3) | 22 (68.8) | 1.38 (0.89–2.17) | 1.38 (0.87–2.18) |
Residence | ||||
Urban | 129 (52.2) | 118 (47.8) | 1.00 | 1.00 |
Rural | 31 (37.3) | 52 (62.7) | 1.31 (0.95–1.82) | 1.25 (0.89–1.73) |
Sex, age, type of patient, contact with MDR-TB patient, diabetes mellitus, HIV coinfection, and residence were included in the model. Treatment delay was categorized into short (< 105 days) and long (≥ 105 days). Abbreviations: MDR-TB, multidrug-resistant tuberculosis; CRR, crude risk ratio; ARR, adjusted risk ratio.
* p value < 0.05 was significant